Patent 7854733 was granted and assigned to Biosense Webster on December, 2010 by the United States Patent and Trademark Office.
Apparatus is provided for ablating tissue of a patient by applying ultrasound energy to the tissue. The apparatus is typically delivered to the targeted tissue via a catheter and includes an ultrasound array, which is adapted to be driven as a phased array to concentrate the ultrasound energy on the targeted tissue while avoiding surrounding tissue.